Team

Thomas Balland

Investment Director

• Thomas Balland is an investment director and specializes in software, wireless and medical devices investments. He assesses investment opportunities, conducts due diligence, leads negotiations and transaction closings, and actively monitors portfolio companies. Thomas currently serves on the boards of CMC Biologics, Monte Cristo, Navx, SpineGuard, SpineVision and Traqueur (Alternext: ALTRA) and is responsible for investments in Paion (Frankfort Stock Exchange: PA8) and ProStrakan (LSE: PSK).
  Thomas sat on the Board of Innoven portfolio company gate5 AG, which was sold to Nokia in 2006. He was also involved with Digiplug, sold to Faith (Tokyo Stock Exchange: 4295).

• Thomas has over 8 years of venture capital investment experience. Prior to joining Innoven in 2002, he held various positions with firms such as Mars Inc., Up&Up and Vivendi.

• Thomas received dual degrees in engineering and finance from INSA Lyon and ESCP-EAP respectively.